Fundz

In Med Pharmaceuticals Inc. reported raising $4.31 Million in an initial SEC Form D filing, from an offering of $4.31 Million

PUBLIC · INMOct 28, 2021

Amount Raised

$4.31 Million

$4.31 Million sold, per SEC Form D (first sale Oct 28, 2021)

Round Type

Seed

VancouverHealthcare

Quick answer

InMed Pharmaceuticals raised $4.31 Million in a Seed round, dated October 28, 2021. InMed Pharmaceuticals is based in Vancouver, British Columbia, Canada.

How much did InMed Pharmaceuticals raise?
InMed Pharmaceuticals raised $4.31 Million in a Seed round on October 28, 2021.
What does InMed Pharmaceuticals do?
InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids.
Where is InMed Pharmaceuticals based and how big is it?
InMed Pharmaceuticals is based in Vancouver, British Columbia, Canada. Fundz records about 16 employees.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as InMed Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Biofrontera raised $15M on December 10, 2021.
  • SpineThera, Inc. raised $1.2M (Seed) on December 10, 2021.
  • MiRTLE Medical raised $525K on December 10, 2021.
  • Hygieia raised $5.8M on December 9, 2021.
  • PetDx, Inc. raised $62M (Series B) on December 9, 2021.
  • iSpecimen raised $21M on December 9, 2021.

Who to call at InMed Pharmaceuticals, and when

A new round usually means InMed Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day InMed Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at InMed Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at InMed Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

InMed Pharmaceuticals

Location

815 W. HASTINGS STREET

Vancouver, British Columbia, Canada

About

InMed Pharmaceuticals is a global leader in the development, manufacturing and commercialization of rare cannabinoids. Together with our subsidiary, BayMedica, we have unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visit www.inmedpharma.com. Nasdaq: INM

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment InMed Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for InMed Pharmaceuticals's next move

See what Strategic adds

InMed Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.